Danielle Oh

Dr. Danielle Oh is a Clinical and Laboratory Haematologist and Clinical Lead for Cellular Therapies at Monash Health. She is a Research Fellow at the Cancer Therapeutics Laboratory, Monash Health Translation Precinct, and recipient of the Monash Partners Clinician Fellowship Program. Her expertise spans haematological malignancies, CAR-T cell therapy, and translational research. Dr. Oh established the Cellular Therapies Program at Monash Health (2023), advancing access to stem cell transplantation and innovative cancer treatments.

Education: PhD in Cancer Therapeutics from Monash University (2023), focusing on dual inhibition of PI3K/BET bromodomain proteins. Completed Lymphoma and Transplant Fellowship at Tom Baker Cancer Centre, Calgary, Canada.

Research Interests: Haematological malignancies, lymphoma, myeloma, cellular therapies, and translational oncology. Active in clinical trials for CAR-T cell therapies and multiple myeloma treatments.

Key Projects: Leading 7 active projects including Phase 3 trials for GPRC5D-directed CAR-T therapy, epcoritamab clinical trials, and the NORM platform study for orphan myeloma. Recipient of multiple awards, including the Albert Baikie Memorial Medal (2020) and NHMRC Postgraduate Scholarship (2018).